# Alivus Life Sciences Ltd (ALIVUS)
> Exchange: NSE | Sector: Pharma | ISIN: INE03Q201024

## About
Alivus Life Sciences Ltd is a Pharma company listed on NSE.
Sector: Pharma

## Returns
1Y Return: 59.84%

## Profitability
ROE: 18.4%

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-09-10T03:46:00.000Z
Price History Updated: 2026-09-09T20:56:15.207Z
Latest Price History Date: 2026-09-03
Technicals Updated: 2026-09-09T20:56:15.207Z
Quant Updated: 2026-09-09T20:56:15.207Z
Sentiment Updated: 2026-09-09T20:56:15.207Z
Financials Status: current
Financials Updated: 2026-09-11T18:28:07.234Z
Financials Last Attempt: 2026-09-11T18:28:07.234Z
Financials Provider Tried: yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (FY26)
Revenue: ₹2504.19 Cr
Operating Profit: ₹722.47 Cr (OPM 28.85%)
Net Profit: ₹564.48 Cr
Tax: ₹186.83 Cr

## Annual P&L History
FY26: Rev ₹2504.19Cr | PAT ₹564.48Cr | OPM 28.85%
FY25: Rev ₹2339.84Cr | PAT ₹485.63Cr | OPM 26.66%
FY24: Rev ₹2184.77Cr | PAT ₹470.89Cr | OPM 28.48%

## Balance Sheet (FY26)
Total Assets: ₹3982.9 Cr
Total Liabilities: ₹3982.9 Cr
Borrowings: ₹56.77 Cr
Cash: ₹1.98 Cr

## Shareholding
Promoters: 74.87%
FIIs: 5.54%
DIIs: 7.18%
Public: 12.42%

---
Source: rupiya.io/stocks/alivus
Disclaimer: For research and education only. Not investment advice.